miR-3960 from Mesenchymal Stem Cell-Derived Extracellular Vesicles Inactivates SDC1/Wnt/<i>β</i>-Catenin Axis to Relieve Chondrocyte Injury in Osteoarthritis by Targeting PHLDA2

<div>MSCs-EVs carrying miR-3960 inhibits PHLDA2 to suppress SDC1 and the Wnt/<i>β</i>-catenin pathway activation, thereby repressing the chondrocyte injury in OA.</div>

Stem Cells International

fig9

Figure 9

Figure 9: miR-3960 from Mesenchymal Stem Cell-Derived Extracellular Vesicles Inactivates SDC1/Wnt/<i>β</i>-Catenin Axis to Relieve Chondrocyte Injury in Osteoarthritis by Targeting PHLDA2 

Figure 9 | miR-3960 from Mesenchymal Stem Cell-Derived Extracellular Vesicles Inactivates SDC1/Wnt/β-Catenin Axis to Relieve Chondrocyte Injury in Osteoarthritis by Targeting PHLDA2 